Facing global food shortages, will ESG investing embrace sustainable gene-edited crops — or continue to reject biotech?

Facing global food shortages, will ESG investing embrace sustainable gene-edited crops — or continue to reject biotech?

Bloomberg | 
The need to feed an expanding population while cutting agriculture’s high greenhouse gas emissions means farming must become more efficient ...
Bayer Monsanto What They Make e

Viewpoint: $2 billion glyphosate-cancer damages highlight why science is ‘no match’ for a persuasive lawyer

Bloomberg | 
Bayer AG hoped it could rely on science to establish the safety of its Roundup weedkiller. But it has clearly ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists